미국의 상처 세척 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 제형별, 용도별, 최종 용도별, 부문별 예측(2026-2033년)

U.S. Wound Wash Market Summary

The U.S. wound wash market size was estimated at USD 321.08 million in 2025 and is projected to reach USD 482.07 million by 2033, growing at a CAGR of 5.2% from 2026 to 2033. The market growth is driven by the increasing number of surgical procedures performed across the country.

Moreover, the rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is anticipated to propel the market growth in the coming years. For instance, according to data published by Healogics, LLC, in August 2024, an estimated 7 million Americans live with chronic or non-healing wounds.

The growing aging population and advancements in surgical techniques contribute to a higher demand for effective wound care solutions, including wound wash products. The U.S. wound wash market is experiencing significant growth, driven by the increasing number of surgical procedures performed across the country. The growing aging population and advancements in surgical techniques contribute to a higher demand for effective wound care solutions, including wound wash products. The increasing number of general, orthopedic, cardiovascular, and plastic surgeries has led to a surge in post-operative wound management needs. Surgical wounds require proper cleaning to prevent infections, promote faster healing, and reduce complications. Wound wash solutions, which irrigate and cleanse wounds without causing tissue damage, have become essential in post-surgical care. According to the American Society of Plastic Surgeons (ASPS), 26.2 million surgical and minimally invasive cosmetic and reconstructive procedures were performed in the U.S. in 2022.

The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is anticipated to propel the market growth in the coming years. According to a study published by the American Medical Association in November 2023, around 34% of individuals with diabetes develop a foot ulcer during their lifetime. Diabetic foot ulcers impact about 1.6 million individuals in the U.S. each year. Moreover, a study published by the National Library of Medicine in January 2024 highlighted that approximately 2.5 million hospitalizations in the U.S. can be attributed to pressure ulcers.

As the older population in the U.S. continues to grow, the incidence of chronic wounds is expected to rise. Data from the Population Reference Bureau, published in January 2024, projects that the number of individuals aged 65 and over in the U.S. likely to increase from 58 million in 2022 to 82 million by 2050-a 47% rise. Moreover, the share of this age group within the total population is expected to grow from 17% to 23%. These expanding elderly demographic is anticipated to drive a substantial increase in the prevalence of chronic wounds, further boosting the demand for wound wash products.

Advancements in wound and surgical washes are a significant driver of the U.S. wound wash market. Traditional wound cleansing methods have evolved with advancements in antimicrobial agents, biofilm-disrupting solutions, and automated irrigation systems, making wound care more effective and efficient. The shift toward advanced antimicrobial solutions is one of the most essential factors driving the wound wash market. Traditionally, wound care involved basic saline or sterile water irrigation, but research has led to antiseptic solutions that actively prevent infections and promote healing. Silver has long been known for its antimicrobial properties. Modern wound wash solutions incorporate silver nanoparticles or sulfadiazine to provide broad-spectrum antimicrobial activity. As per the National Library of Medicine, silver-based solutions benefit burns, chronic wounds, and post-surgical care by reducing bacterial colonization and biofilm formation. They provide a sustained antimicrobial effect without harming healthy tissue.

U.S. Wound Wash Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound wash market report based on product, product form, application, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Antiseptic
  • Povidone Iodine
  • Chlorhexidine
  • Polyhexanide (PHMB)
  • Others
• Saline Solution
• Irrigation Solution
• Pulsed Lavage Systems
  • Disposable
  • Reusable
  • Semi Disposable
• Others
• Product Form Outlook (Revenue, USD Million, 2021 - 2033)
• Solutions
• Sprays
• Wipes
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Wounds
  • Surgical & Traumatic Wounds
  • Burns & Lacerations
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers
• Military & Defense
• Others

Table of Content

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Wound Wash Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing number of surgical procedures
    • 3.2.1.2. Rising prevalence of chronic wounds
    • 3.2.1.3. Advancements in wound and surgical washes
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent regulatory approvals & compliance costs
    • 3.2.2.2. Adverse events and complications associated with the use of wound wash
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Increasing demand for wound wash products from the military and defense sector
    • 3.2.3.2. Increasing number of hospitals and surgical facilities
    • 3.2.3.3. Rising number of clinical trials
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Rising competition among industry participants
• 3.3. U.S. Wound Wash Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Wash Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Wound Wash Market Product Movement Analysis
• 4.3. U.S. Wound Wash Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Antiseptic
  • 4.4.1. Antiseptic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Povidone Iodine
    • 4.4.2.1. Povidone Iodine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Chlorhexidine
    • 4.4.3.1. Chlorhexidine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Polyhexanide (PHMB)
    • 4.4.4.1. Polyhexanide (PHMB) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Saline Solution
  • 4.5.1. Saline Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Irrigation Solution
  • 4.6.1. Irrigation Solution Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Pulsed Lavage Systems
  • 4.7.1. Pulsed Lavage Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. Disposable
    • 4.7.2.1. Disposable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. Reusable
    • 4.7.3.1. Reusable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7.4. Semi Disposable
    • 4.7.4.1. Semi Disposable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Wash Market: Product Form Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Wound Wash Market Product Form Movement Analysis
• 5.3. U.S. Wound Wash Market Size & Trend Analysis, by Product Form, 2021 to 2033 (USD Million)
• 5.4. Solutions
  • 5.4.1. Solutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Sprays
  • 5.5.1. Sprays Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Wipes
  • 5.6.1. Wipes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Wash Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Wound Wash Market Application Movement Analysis
• 6.3. U.S. Wound Wash Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Acute Wounds
  • 6.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Surgical & Traumatic Wounds
    • 6.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Burns & Lacerations
    • 6.4.3.1. Burns & Lacerations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Chronic Wounds
  • 6.5.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Diabetic Foot Ulcers
    • 6.5.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Pressure Ulcers
    • 6.5.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. Venous Leg Ulcers
    • 6.5.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. Other Chronic Wounds
    • 6.5.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Wash Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Wound Wash Market End Use Movement Analysis
• 7.3. U.S. Wound Wash Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Specialty Clinics
  • 7.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Military & Defense
  • 7.7.1. Military & Defense Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Atlantis Consumer Healthcare Inc.
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Service Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Medline Industries, LP
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Service Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. B. Braun SE
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Service Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Johnson & Johnson Consumer Inc. (Johnson & Johnson)
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Service Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Zimmer Biomet
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Service Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Urgo Medical North America (URGO Group)
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Service Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Coloplast Corp (Coloplast Group)
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Service Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Molnlycke Health Care AB
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Service Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Cardinal Health
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Service Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Armis Biopharma
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Service Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. Bravida Medical
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Service Benchmarking
    • 8.2.11.4. Strategic Initiatives
  • 8.2.12. Irrimax Corporation
    • 8.2.12.1. Company Overview
    • 8.2.12.2. Financial Performance
    • 8.2.12.3. Service Benchmarking
    • 8.2.12.4. Strategic Initiatives
  • 8.2.13. BD
    • 8.2.13.1. Company Overview
    • 8.2.13.2. Financial Performance
    • 8.2.13.3. Service Benchmarking
    • 8.2.13.4. Strategic Initiatives
  • 8.2.14. Sanara MedTech Inc.
    • 8.2.14.1. Company Overview
    • 8.2.14.2. Financial Performance
    • 8.2.14.3. Service Benchmarking
    • 8.2.14.4. Strategic Initiatives
  • 8.2.15. Pure&Clean
    • 8.2.15.1. Company Overview
    • 8.2.15.2. Financial Performance
    • 8.2.15.3. Service Benchmarking
    • 8.2.15.4. Strategic Initiatives
  • 8.2.16. Innovacyn, Inc.
    • 8.2.16.1. Company Overview
    • 8.2.16.2. Financial Performance
    • 8.2.16.3. Service Benchmarking
    • 8.2.16.4. Strategic Initiatives